Twenty-Five Years of Intracranial Pressure Monitoring After Severe Traumatic Brain Injury: A Retrospective, Single-Center Analysis.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 16 04 2018
accepted: 11 09 2018
pubmed: 27 11 2018
medline: 25 3 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

Intracranial pressure (ICP) is a clinically important variable after severe traumatic brain injury (TBI) and has been monitored, along with clinical outcome, for over 25 yr in Addenbrooke's hospital, Cambridge, United Kingdom. This time period has also seen changes in management strategies with the implementation of protocolled specialist neurocritical care, expansion of neuromonitoring techniques, and adjustments of clinical treatment targets. To describe the changes in intracranial monitoring variables over the past 25 yr. Data from 1146 TBI patients requiring ICP monitoring were analyzed. Monitored variables included ICP, cerebral perfusion pressure (CPP), and the cerebral pressure reactivity index (PRx). Data were stratified into 5-yr epochs spanning the 25 yr from 1992 to 2017. CPP increased sharply with specialist neurocritical care management (P < 0.0001) (introduction of a specific TBI management algorithm) before stabilizing from 2000 onwards. ICP decreased significantly over the 25 yr of monitoring from an average of 19 to 12 mmHg (P < 0.0001) but PRx remained unchanged. The mean number of ICP plateau waves and the number of patients developing refractory intracranial hypertension both decreased significantly. Mortality did not significantly change in the cohort (22%). We demonstrate the evolving trends in neurophysiological monitoring over the past 25 yr from a single, academic neurocritical care unit. ICP and CPP were responsive to the introduction of an ICP/CPP protocol while PRx has remained unchanged.

Sections du résumé

BACKGROUND
Intracranial pressure (ICP) is a clinically important variable after severe traumatic brain injury (TBI) and has been monitored, along with clinical outcome, for over 25 yr in Addenbrooke's hospital, Cambridge, United Kingdom. This time period has also seen changes in management strategies with the implementation of protocolled specialist neurocritical care, expansion of neuromonitoring techniques, and adjustments of clinical treatment targets.
OBJECTIVE
To describe the changes in intracranial monitoring variables over the past 25 yr.
METHODS
Data from 1146 TBI patients requiring ICP monitoring were analyzed. Monitored variables included ICP, cerebral perfusion pressure (CPP), and the cerebral pressure reactivity index (PRx). Data were stratified into 5-yr epochs spanning the 25 yr from 1992 to 2017.
RESULTS
CPP increased sharply with specialist neurocritical care management (P < 0.0001) (introduction of a specific TBI management algorithm) before stabilizing from 2000 onwards. ICP decreased significantly over the 25 yr of monitoring from an average of 19 to 12 mmHg (P < 0.0001) but PRx remained unchanged. The mean number of ICP plateau waves and the number of patients developing refractory intracranial hypertension both decreased significantly. Mortality did not significantly change in the cohort (22%).
CONCLUSION
We demonstrate the evolving trends in neurophysiological monitoring over the past 25 yr from a single, academic neurocritical care unit. ICP and CPP were responsive to the introduction of an ICP/CPP protocol while PRx has remained unchanged.

Identifiants

pubmed: 30476233
pii: 5200881
doi: 10.1093/neuros/nyy468
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E75-E82

Subventions

Organisme : Department of Health
ID : II-C5-0715-20005
Pays : United Kingdom
Organisme : Department of Health
ID : 12/35/57
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1002277
Pays : United Kingdom
Organisme : Department of Health
ID : HTA/13/15/02
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0001237
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR-RP-R3-12-013
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0502030
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9439390
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601025
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600986
Pays : United Kingdom

Informations de copyright

Copyright © 2018 by the Congress of Neurological Surgeons.

Auteurs

Joseph Donnelly (J)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Department of Anaesthesiology, University of Auckland, Auckland, New Zealand.

Marek Czosnyka (M)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Institute of Electronic Systems, Warsaw University of Technology, Warsaw, Poland.

Hadie Adams (H)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.

Danilo Cardim (D)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.

Angelos G Kolias (AG)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, United Kingdom.

Frederick A Zeiler (FA)

Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Clinician Investigator Program, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.

Andrea Lavinio (A)

Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

Marcel Aries (M)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Department of Intensive Care, University of Maastricht, Maastricht University Medical Center, Maastricht, Netherlands.

Chiara Robba (C)

Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Department of Anaesthesia and Intensive Care, Policlinico San Martino, IRCCS for Oncology, University of Genoa, Genoa, Italy.

Peter Smielewski (P)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.

Peter J A Hutchinson (PJA)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, United Kingdom.
Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.

David K Menon (DK)

NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, United Kingdom.
Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

John D Pickard (JD)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.

Karol P Budohoski (KP)

Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, United Kingdom.
Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH